調査レポートカテゴリー： MarketsandMarkets, ヨーロッパ, 医療/バイオ

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

欧州のNGS（次世代シークエンシング）サービス市場

◆タイトル：European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
◆商品コード：MAM-BT-3781
◆調査・発行会社：MarketsandMarkets
◆発行日：2015年10月13日
◆ページ数：213
◆レポート形式：PDF / 英語
◆納品方法：Eメール
◆調査対象地域：欧州
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、欧州のNGS（次世代シークエンシング）サービス市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、用途別分析、需要先別分析、疾患別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country.

The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference of NGS over other platforms; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities. Technological advancements have widened the scope of NGS as they assist in the detection of various tumors, malignancies, and other oncological conditions in the early stages. Cancer genomes are extremely complex and diverse; NGS is used to detect mutations and perform many tests at once in such heterogeneous samples; thus playing an important role in cancer research.

Apart from comprehensive technology, application, end-user, and country-level analysis and market sizing, the report also provides the company profiles which comprise basic views on key players with regard to business overview, service offerings, and developments in this market. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding service offerings, regional focus, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, new services/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Information on the service portfolios of the key players in the European NGS services market. The report analyzes this market by technology, application, end user, disease type, and region
• NGS Services/Innovations: Insights on R&D activities and new service launches in the European NGS services market
• Competitive Assessment: In-depth assessment of geographical & business segments and service portfolios of some of the key players in the European NGS services market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various NGS technologies and applications across regions
• Market Diversification: Information about new services, recent developments, and investments in the European NGS services marke

【レポートの目次】

1 Introduction
1.1 Objectives
1.2 Market Definitions
1.3 Market Scope

2 Research Methodology

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.2 Restraints
4.4.3 Opportunities
4.4.4 Challenges

5 Industry Insights
5.1 Pricing Analysis
5.2 Investor Analysis
5.3 Pestel Analysis

6 Regulation and Certification Landscape

7 Customer Perception Analysis

8 Benchmark Parameters and Futuristic Trends

9 European NGS Services Market, By Technology
9.1 SBS
9.2 ION Semiconductor
9.3 SBL
9.4 Pyro-Sequencing
9.5 Smrt

10 European NGS Services Market, By Application
10.1 Application (I)
10.1.1 Research Applications
10.1.2 Clinical Applications
10.2 Application (II)
10.2.1 Rna-Sequencing
10.2.2 Targeted Sequencing
10.2.3 Exome Sequencing
10.2.4 Whole Genome Sequencing
10.2.5 Chip-Sequencing
10.2.6 Methyl-Sequencing
10.2.7 De Novo Sequencing
10.2.8 Others

11 European NGS Services Market, By Disease Type
11.1 Overview
11.2 Oncology
11.2.1 Lung Cancer
11.2.2 Breast Cancer
11.2.3 Prostate Cancer
11.2.4 Colorectal Cancer
11.2.5 Others
11.3 Rare Diseases
11.4 Prenatal/Neonatal Disorders
11.5 Others

12 European NGS Services Market, By End User
12.1 Research Centers, Academic & Government Institutes
12.2 Hospitals & Clinics
12.3 Pharmaceutical & Biotechnology Companies
12.4 Others

13 European NGS Services Market, By Geography
13.1 Introduction
13.2 U.K.
13.3 Germany
13.4 France
13.5 Italy
13.6 Spain
13.7 Netherlands
13.8 Rest of the Europe (RoE)

14 Competitive Landscape
14.1 New Product Launches
14.2 Government Funding
14.3 Market Share Analysis

15 Company Profiles
15.1 Beijing Genomics Institute (BGI)
15.2 Cegat (Centre for Genomics and Transcriptomics) GmbH
15.3 DNA Vision SA
15.4 Eurofins Genomics Inc.
15.5 Febit / Comprehensive Biomarker Center GmbH (CBC)
15.6 Genomnia Srl
15.7 Illumina Inc.
15.8 Macrogen Inc.
15.9 Microsynth AG
15.10 Seqomics
15.11 Source Bio Science

16 Appendix
16.1 Certified NGS Service Providers in Europe
16.2 Major End Users of NGS Services
16.3 Related Reports

List of Tables (67 Tables)

Table 1 European NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 2 SBS Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 3 ION Semiconductor Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 4 SBL Technology-Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 5 Pyrosequencing Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 6 Smart Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 7 European NGS Services Market Size, By Application (I), 2013-2020 (USD Million)
Table 8 NGS Services Market Size for Research Applications, By Country, 2013-2020 (USD Million)
Table 9 NGS Services Market Size for Clinical Applications, By Country, 2013-2020 (USD Million)
Table 10 European NGS Services Market Size, By Application (II), 2013-2020 (USD Million)
Table 11 RNA-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 12 Targeted Sequencing/Gene Panels Services Market Size, By Country, 2013-2020 (USD Million)
Table 13 Exome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 14 Whole Genome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 15 Chip-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 16 Methyl-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 17 De Novo Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 18 Other Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 19 NGS Services Market Size, By Disease Type, 2013–2020 (USD Million)
Table 20 European NGS Oncology Services Market, By Cancer Type, 2013-2020 (USD Million)
Table 21 NGS Services Market Size for Lung Cancer, By Country, 2013-2020 (USD Million)
Table 22 NGS Services Market Size for Breast Cancer, By Country, 2013-2020 (USD Million)
Table 23 NGS Services Market Size for Prostate Cancer, By Country, 2013-2020 (USD Million)
Table 24 NGS Services Market Size for Colorectal Cancer, By Country, 2013-2020 (USD Million)
Table 25 NGS Services Market Size for Other Oncology Diseases, By Country, 2013-2020 (USD Million)
Table 26 European NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 27 NGS Services Market Size for Research Centers, Academic & Government Institutes, By Country, 2013-2020 (USD Million)
Table 28 NGS Services Market Size for Hospitals & Clinics, By Country, 2013-2020 (USD Million)
Table 29 NGS Services Market Size for Pharmaceutical & Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 30 NGS Services Market Size for Other End Users, By Country, 2013-2020 (USD Million)
Table 31 European NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 32 European Oncology NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 33 U.K.: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 34 U.K.: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 35 U.K.: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 36 U.K.: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 37 U.K.: NGS Oncology Services Market Size, By Type, 2013-2020 (USD Million)
Table 38 Germany: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 39 Germany: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 40 Germany: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 41 Germany: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 42 Germany: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 43 France: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 44 France: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 45 France: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 46 France: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 47 France: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 48 Italy: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 49 Italy: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 50 Italy: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 51 Italy: NGS Services Market Size, By Applications, (II) 2013-2020 (USD Million)
Table 52 Italy: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 53 Spain: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 54 Spain: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 55 Spain: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 56 Spain: NGS Services Market Size, By Applications (II) 2013-2020 (USD Million)
Table 57 Spain: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 58 Netherlands: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 59 Netherlands: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 60 Netherlands: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 61 Netherlands: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 62 Netherlands: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 63 RoE: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 64 RoE: NGS Services Market Size, By Applications(I), 2013-2020 (USD Million)
Table 65 RoE: NGS Services Market Size, By End-User , 2013-2020 (USD Million)
Table 66 RoE: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 67 RoE: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)

List of Figures (12 Figures)

Figure 1 Market Size, 2015-2020 (USD Million)
Figure 2 Customer Segmentation, 2015
Figure 3 Country-Wise Market Share, 2015
Figure 4 Market Size, 2014–2020 (USD Million)
Figure 5 Pricing Analysis
Figure 6 European NGS Services Market Size, By Technology, 2015 & 2020 (USD Million)
Figure 7 Market Size, By Technology, 2011–2020 (USD Million)
Figure 8 Market Size, By Applications (I), 2015 & 2020 (USD Million)
Figure 9 Market Size, By Application (II), 2015 & 2020 (USD Million)
Figure 10 Market Size, By Disease Type, 2015 & 2020 (USD Million)
Figure 11 Market Size, By End User, 2011–2020 (USD Million)
Figure 12 Market Share (2014)

【レポートのキーワード】

NGS（次世代シークエンシング）、NGSサービス、医療、癌

★調査レポート[欧州のNGS（次世代シークエンシング）サービス市場] ( European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020 / MAM-BT-3781) 販売に関する免責事項
[欧州のNGS（次世代シークエンシング）サービス市場] ( European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020 / MAM-BT-3781) についてEメールでお問い合わせ
◆関連調査資料◆
  • ゲノミクスの世界市場予測（～2022年）：装置/システム、消耗品、サービス
    MAM-BT-2209 / MarketsandMarkets / 2017年10月6日 / MarketsandMarketsが発行した当調査レポートでは、ゲノミクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス別分析、技術別分析、プロセス別分析、用途別分析、ゲノミクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global Genomics market is expected to reach USD 23.88 Billion by 2022 from USD 14.71 Billion in 2017, at a CAGR of 10.2%. The growth of this market is majorly driven by the rise in research activities in the field of genomics; increasing number of start-up companies; growing focus personalized medicine, growing investments, grants, and funds by the government; and increasing application of genomic sequencing in the diagnostics. The report analyzes the genomics market by product and services, technology, process, application, end user and region. The products and services of genomics market is segmented into instruments/systems, consumables and services....
  • NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場予測（～2022年）
    MAM-BT5297 / MarketsandMarkets / 2017年5月26日 / 当調査レポートでは、NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品・サービス別分析、技術別分析、需要先別分析、地域別分析、NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global NGS-based RNA-seq market is projected to reach USD 2.65 Billion by 2022 from USD 1.05 Billion in 2017, at a CAGR of 20.2% during the forecast period. The advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-Seq grants, increasing number of research activities, and rapid growth in precision medicine are the key factors driving the growth of the market. On the other hand, lack of skilled professionals and standardization concerns of RNA-seq in diagnostic testing are some of the key factors limiting the growth of the market. The increasing applications of RNA-seq...
  • がん用バイオマーカーの世界市場予測（～2022年）：タンパク質バイオマーカー、遺伝子バイオマーカー
    MAM-MD-5627 / MarketsandMarkets / 2017年10月5日 / MarketsandMarketsが発行した当調査レポートでは、がん用バイオマーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、がんタイプ別分析、技術別分析、用途別分析、がん用バイオマーカーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and rising demand for personalized medicine in cancer therapies. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market. The cancer biomarkers...
  • 次世代シーケンシング（NGS）の世界市場予測（～2022）
    MAM-BT2697 / MarketsandMarkets / 2017年4月4日 / 当調査レポートでは、次世代シーケンシング（NGS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品種類別分析、サービス別分析、用途別分析、地域別分析、次世代シーケンシング（NGS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The next-generation sequencing market is expected to reach USD 12.45 Billion by 2022 from USD 4.90 Billion in 2017, at a CAGR of 20.5% between 2017 and 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market. In addition, storage of sequencing data and interpretation...
  • 次世代シーケンシング（NGS）の世界市場予測（～2024年）
    BT-2697 / MarketsandMarkets / 2018年8月23日 / MarketsandMarketsが発行した当調査レポートでは、次世代シーケンシング（NGS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（NovaSeq、NextSeq、Sequel、ナノポア）分析、消耗品・バイオインフォマティクス・サービス別（エクソーム、RNA、DeNovo）分析、技術別（イオン、SMRT）分析、用途別（診断、がん）分析、次世代シーケンシング（NGS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2% during the forecast period. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are expected to drive the growth of the next-generation sequencing market. The report analyzes the global next-generation sequencing market, by product & service, technology, application, end user, and region. On the basis of product & service, the next-generation sequencing market is segmented into...
  • 次世代シーケンシング（NGS）サービスの世界市場予測（～2022年）
    MAM-BT5526 / MarketsandMarkets / 2017年8月24日 / MarketsandMarketsが発行した当調査レポートでは、次世代シーケンシング（NGS）サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、技術別分析、用途別分析、地域別分析、次世代シーケンシング（NGS）サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%”The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing, the high cost of sequencing infrastructure, the need for skilled professionals for efficient NGS sample preparation and analysis, and technological advancements in the field of sequencing are driving the growth of this market. However, installation of in-house sequencing facilities in hospitals and universities is expected to limit the...
  • 分子診断の世界市場予測（～2023年）
    MD2521 / MarketsandMarkets / 2018年5月24日 / MarketsandMarketsが発行した当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途（感染症、がん診断、遺伝子検査）別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global molecular diagnostics market is projected to grow at a CAGR of 8.4%.”The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market...
  • 腫瘍栄養の世界市場予測（～2023年）
    PH6225 / MarketsandMarkets / 2018年4月30日 / 当調査レポートでは、腫瘍栄養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、腫瘍種類別分析、地域別分析、腫瘍栄養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023.”The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also...
  • マイクロバイオーム・シーケンシング・サービスの世界市場予測（～2021年）
    MAM-BT5306 / MarketsandMarkets / 2017年5月30日 / 当調査レポートでは、マイクロバイオーム・シーケンシング・サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別分析、用途別分析、種類別分析、需要先別分析、マイクロバイオーム・シーケンシング・サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global microbiome sequencing services market is poised to reach USD 1424.7 million by 2021 from USD 538.0 million in 2016, at a CAGR of 21.5% from 2016 to 2021. The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services. In this report, the global microbiome sequencing services market is broadly segmented by technology, application, research type, laboratory type, end user, and region. On the basis of application, the microbiome sequencing services market is segmented into shotgun sequencing, targeted gene...
  • 分子診断の世界市場予測（～2021年）
    MAM-MD-2521 / MarketsandMarkets / 2017年2月2日 / 当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil,...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆